135 related articles for article (PubMed ID: 31197453)
1. Aberrant expression of Sec61α in esophageal cancers.
Bachmann K; Bockhorn M; Mann O; Gebauer F; Blessmann M; Izbicki JR; Grupp K
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2039-2044. PubMed ID: 31197453
[TBL] [Abstract][Full Text] [Related]
2. FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas.
Grupp K; Uzunoglu FG; Melling N; Hofmann B; El Gammal AT; Grotelüschen R; Heumann A; Bellon E; Reeh M; Wolters-Eisfeld G; Ghabdan T; Nentwich M; Bachmann K; Bockhorn M; Bogoevski D; Izbicki JR; Kutup A
Sci Rep; 2018 Nov; 8(1):17370. PubMed ID: 30478420
[TBL] [Abstract][Full Text] [Related]
3. Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
Bellon E; Grupp K; Ghadban T; Tachezy M; Bachmann K; Izbicki JR; Simon R; Sauter G; Hube-Magg C; Melling N
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2879-2884. PubMed ID: 34148155
[TBL] [Abstract][Full Text] [Related]
4. High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.
El Gammal AT; Melling N; Reeh M; Gebauer F; Mann O; Perez D; Bockhorn M; Bachmann K; Izbicki JR; Grupp K
Exp Mol Pathol; 2019 Apr; 107():51-56. PubMed ID: 30707896
[TBL] [Abstract][Full Text] [Related]
5. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
6. Programmed cell death 4 protein in esophageal cancer.
Fassan M; Cagol M; Pennelli G; Rizzetto C; Giacomelli L; Battaglia G; Zaninotto G; Ancona E; Ruol A; Rugge M
Oncol Rep; 2010 Jul; 24(1):135-9. PubMed ID: 20514454
[TBL] [Abstract][Full Text] [Related]
7. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
[TBL] [Abstract][Full Text] [Related]
8. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.
Grupp K; Hofmann B; Kutup A; Bachmann K; Bogoevski D; Melling N; Uzunoglu FG; El Gammal AT; Koop C; Simon R; Steurer S; Krech T; Burdak-Rothkamm S; Jacobsen F; Sauter G; Izbicki J; Wilczak W
BMC Cancer; 2018 Nov; 18(1):1106. PubMed ID: 30419865
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population.
Rong L; Liu Y; Hui Z; Zhao Z; Zhang Y; Wang B; Yuan Y; Li W; Guo L; Ying J; Song Y; Wang L; Zhou Z; Xue L; Lu N
Diagn Pathol; 2019 Jan; 14(1):6. PubMed ID: 30684971
[TBL] [Abstract][Full Text] [Related]
10. FOXA1 and CK7 expression in esophageal squamous cell carcinoma and its prognostic significance.
Xu Y; Wang W; Li L; Liu J; Wu X; Yu J; Wang H; Cui W; Zhang R
Neoplasma; 2018 Mar; 65(3):469-476. PubMed ID: 29788741
[TBL] [Abstract][Full Text] [Related]
11. CD147 expression lacks prognostic relevance in esophageal cancer.
Küsters N; Grupp K; Grass JK; Bachmann K; Ghadban T; Uzunoglu FG; Tachezy M; Perez D; Reeh M; Izbicki JR; Melling N
J Cancer Res Clin Oncol; 2022 Apr; 148(4):837-844. PubMed ID: 34997863
[TBL] [Abstract][Full Text] [Related]
12. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.
Kilic E; Tennstedt P; Högner A; Lebok P; Sauter G; Bokemeyer C; Izbicki JR; Wilczak W
Virchows Arch; 2016 Apr; 468(4):483-92. PubMed ID: 26818834
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
[TBL] [Abstract][Full Text] [Related]
15. Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
Abraham SC; Wang H; Wang KK; Wu TT
Am J Surg Pathol; 2008 Jul; 32(7):1068-74. PubMed ID: 18496141
[TBL] [Abstract][Full Text] [Related]
16. miR-486-5p expression pattern in esophageal squamous cell carcinoma, gastric cancer and its prognostic value.
Ren C; Chen H; Han C; Fu D; Zhou L; Jin G; Wang F; Wang D; Chen Y; Ma L; Zheng X; Han D
Oncotarget; 2016 Mar; 7(13):15840-53. PubMed ID: 26895105
[TBL] [Abstract][Full Text] [Related]
17. Association of angiogenic factors with prognosis in esophageal cancer.
Dreikhausen L; Blank S; Sisic L; Heger U; Weichert W; Jäger D; Bruckner T; Giese N; Grenacher L; Falk C; Ott K; Schmidt T
BMC Cancer; 2015 Mar; 15():121. PubMed ID: 25885021
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
